Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Preliminary Agenda Available and Exclusive Discount to attend Understanding CRISPR: Mechanisms to Applications Symposium in Boston (September 19, 2016)

Reporter: Aviva Lev-Ari, PhD, RN

@CHI_Healthtech

Preliminary Agenda Available and Exclusive Discount to attend Understanding CRISPR: Mechanisms to Applications Symposium in Boston (September 19, 2016)

The agenda is now available for CHI’s 2^nd Annual Understanding CRISPR: Mechanisms to Applications Symposium (part of the 14^th Annual Discovery on Target taking place September 19 – 22, 2016 in Boston.) Visit http://www.DiscoveryOnTarget.com/Crispr-Therapies for complete details and registration pricing.

Gene editing is rapidly progressing from being a research/screening tool to one that promises important applications downstream in drug development, cell and gene therapy. Cambridge Healthtech Institute’s symposium on Understanding CRISPR: Mechanisms to Applications will bring together experts to talk about how gene editing works and where it can be best applied. How does the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas system, compare to other gene editing tools? What do we now know about the biology of CRISPR and what lessons have we learnt from working with RNA interference (RNAi)? Scientists will discuss new findings in CRISPR mechanisms and share their experiences leveraging the utility of CRISPR-based gene editing.

Talks include:

• Comparing Arrayed siRNA and CRISPR Approaches Towards Functional Genomics Screening
• Getting from Alpha to Omega: Successfully Conceptualizing, Starting and Finishing CRISPR/Cas Screens
• Genome Editing-Enabled HTS Assays for Genetically Inherited Disease Drug Discovery
• Use of CRISPR and Other Genomic Technologies to Advance Drug Discovery
• Vignettes From the Bench: CRISPR Engineering Lymphoma Lines
• PANEL DISCUSSION: Will Interference from CRISPR Silence RNAi?
• MicroRNA Target Site Editing of Chondrocyte Master-Regulators in Primary Human Cells Using CRISPR-Cas9
• Massively Parallel Combinatorial Genetic Perturbation Screening with CRISPR-Cas9 in Human Cells
• The Scientist’s Guide to CRISPR Law
• About Discovery on Target:

Discovery on Target showcases current and emerging “hot” targets for the pharmaceutical industry. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, 50+ interactive breakout discussion groups, an exhibit hall of 50+ companies, 100+ posters, and dedicated networking sessions. The 14^th Annual Discovery on Target event assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.

As a proud partner of this event, Leaders in Pharmaceutical Business Intelligence (LPBI) Group has secured a special discounted price for you to attend, resulting in a $200 discount on a commercial registration and $100 discount on an academic registration!

*This offer is valid for new registrants only, does not apply to previously registered attendees or short courses, and cannot be combined with any other offer. You must mention key code LPBI16 to receive this discount.

Don’t miss your opportunity to network with 1,100+ of your peers at this year’s event. Special early registration savings are currently available through Friday, June 3.

We look forward to seeing you this September in Boston, Massachusetts.

Sincerely,
Bethany Gray
Senior Marketing Manager
Cambridge Healthtech Institute
bgray@healthtech.com

For sponsorship & exhibit information, please contact: Jon Stroup, Sr Business Development Manager, 781-972-5483, jstroup@healthtech.com